Anzeige
Mehr »
Donnerstag, 17.09.2026 - Börsentäglich über 12.000 News
Kommerzialisierung der "Super-Exosomen"
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
378 Leser
Artikel bewerten:
(1)

MasterControl Celebrates EMEA Customers' Achievements in 2023

The European Masters of Excellence Awards recognizes leaders in life sciences committed to quality

SALT LAKE CITY, June 07, 2023, a provider of software solutions that enable life sciences and other regulated companies to deliver life-changing products to more people sooner, announced the winners of the European Masters of Excellence Awards during the annual Masters Conference, held in Lisbon, Portugal last month. These awards recognise MasterControl customers who have excelled in quality and manufacturing innovation and are leaders in their respected professions.

Each year, one individual is awarded the European Masters of Excellence Quality Champion, and in 2023 Wilma de Koning, quality assurance systems governance manager for Elekta took home this award. Elekta is a global Swedish company that is leading innovation of precision radiation therapy solutions to ensure that patients have access to the best cancer care possible. De Koning has been an influential leader in quality management working closely with IT to make certain they are using MasterControl and other technology to its full potential. She is a champion of quality looking for opportunities to create efficiency while improving compliance.

OrganOx, a company at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation, received the Innovation Excellence award. Their leading product, metra®, not only helps preserve livers for up to 24 hours prior to transplant, but also enables functional assessment prior to transplant reducing early dysfunction and improving transplantation logistics. OrganOx relies on MasterControl for paperless quality management allowing for greater control of training, investigations, and document changes.

MasterControl recognised Exstent for Digital Transformation in Manufacturing. Exstent has developed a revolutionary new device designed to manage aortic dilation in people with Marfan syndrome and related genetic conditions. To streamline production, Exstent implemented MasterControl Manufacturing Excellence capturing all manufacturing data in a paperless production record and did so within a six-month period. By using modern technology, the company navigated a successful ISO13485:2016 audit, receiving both their ISO and MDSAP certifications.

Klosterfrau accepted the award for Excellence in Analytics, the first time this category has been recognised in EMEA. By using MasterControl Insights, Klosterfrau is able to easily generate reports across different sites, saving time and increasing visibility across operations. Users can combine data from different systems into one report increasing overall report value with clear visualization of the data. Klosterfrau has been developing, manufacturing and selling pharmaceutical products for nearly 200 years. The company offers 30 brand and nearly 200 products that improve the lives of patients.

"The European Masters of Excellence Awards allow us to celebrate the technology and innovation achievements of our customers," says CEO Jon Beckstrand. "Each one of these organizations are positively impacting patient lives and MasterControl is honored to be a partner to these amazing companies and individuals."

About MasterControl

MasterControl Inc. is a leading provider of cloud based quality and manufacturing software for life sciences and other regulated industries. For three decades, our mission has been the same as that of our customers to bring lifechanging products to more people sooner. MasterControl helps organisations digitise, automate, and connect quality and manufacturing processes. Innovative MasterControl tools have a proven track record of improving product quality, reducing cost, and accelerating time to market. Over 1,100 companies worldwide use MasterControl solutions to streamline operations, maintain compliance, easily analyse and interpret large amounts of data, and visualise business insights in real time. For more information, visit www.mastercontrol.com.

Media Contacts:
Jennifer Sefakis, Sr. Director PR
MasterControl
jhurst@mastercontrol.com
+1-801-560-9608


© 2023 GlobeNewswire (Europe)
KI braucht Strom
Halbleiter, Speicherchips und Rechenzentren haben Anlegern im KI-Boom bereits enorme Gewinne beschert. Doch jetzt zeichnet sich mit der benötigten Energie der nächste große Flaschenhals ab. Neue KI-Rechenzentren benötigen nicht mehr einige Megawatt, sondern zum Teil mehrere Gigawatt Leistung – so viel wie mehrere moderne Kernkraftwerksblöcke.

Damit beginnt ein weltweites Wettrennen um verfügbare Stromkapazitäten. Hyperscaler sichern sich bereits über langfristige Verträge gewaltige Energiemengen, während Stromnetze und Erzeugungskapazitäten mit dem Ausbau kaum Schritt halten können. Zusätzlich verschärfen geopolitische Risiken rund um den Iran-Krieg und die Straße von Hormus die Situation.

Für Energieversorger und ihre Zulieferer könnte damit ein goldenes Zeitalter beginnen. Steigende Nachfrage, langfristige Abnahmeverträge und wachsende Strompreise schaffen ein Umfeld, in dem ausgewählte Unternehmen zum nächsten großen KI-Trade werden könnten.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die besonders stark vom explodierenden Energiehunger der KI profitieren könnten – und bei Anlegern bislang teilweise noch unter dem Radar laufen.

Jetzt den kostenlosen Report sichern – und die nächsten Gewinner des KI-Booms entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.